| Home | Search Abstracts | Browse Sessions | Program Committee | Conference Webcasts | Contact Us |
|
Session 110
Poster Abstracts Epidemiology and Natural History of HIV/HCV Co-Infection Tuesday, 1:30 - 3:30 pm Poster Hall |
| 795 | Relationship between HIV and Hepatitis C Viral Genotypes and Routes of Transmission among Blood Donors in Northern Thailand L Thaikruea*1, K E Nelson2, S Thongsawat1, N Maneekarn1, D Netski3, and D L Thomas3 1Chiang Mai Univ. Faculty of Med., Thailand; 2Bloomberg Sch. of Publ. Hlth., Johns Hopkins Univ., Baltimore, MD, USA; and 3Johns Hopkins Univ. Sch. of Med., Baltimore, MD, USA |
| 796 | Hepatitis B, Hepatitis C, and HIV Co-infection in Chennai, India M C Rogers*1, N Kumarasamy2, S K Chaguturu1, T P Flanigan1, K H Mayer1, P Balakrishnan2, and S Solomon2 1Miriam Hosp., Brown Med. Sch., Providence, RI, USA and 2YRG Ctr. for AIDS Res. and Education, Chennai, India |
| 797 | The Role of Hepatitis C in Mortality among People Living with AIDS in New York City K Schlanger1, J Trei*2, and S Factor1 1New York City Dept. of Hlth. and Mental Hygiene, NY, USA and 2Yale Univ. Epidemiology and Publ. Hlth., New Haven, CT, USA |
| 798 | HIV Patients Co-infected with Both HCV and HBV Are at Higer Risk of Death from Liver Disease than Patients Co-infected with HCV or HBV Alone D Salmon*1, C Lewden2, L Heripret3, F Bonnet4, S Bevilacqua5, D Costagliola6, T May3, P Morlat4, and G Chêne2 1CHU Cochin, Paris, France; 2INSERM U593, Bordeaux, France; 3CHU Nice, France; 4CHU Bordeaux, France; 5CHU Nancy, France; and 6INSERM EPI0214, Paris, France |
| 799 | Hepatitis B and Hepatitis C in the EuroSIDA Cohort: Prevalence and Effect on Mortality, AIDS Progression and Response to HAART J Rockstroh*1, D Konopnicki2, V Soriano3, O Kirk4, F Antunes5, B Knysz6, C Tural7, S De Wit2, A Mocroft8, J Lundgren4, and EuroSIDA study group 1Univ. of Bonn, Germany; 2St. Pierre Univ., Brussels, Belgium; 3Inst. de Salud Carlos III, Madrid, Spain; 4Hvidovre Univ. Hosp., Hvidovre, Denmark; 5Faculty of Med., Lisbon, Portugal; 6Wroclaw Univ., Poland; 7Germans Trias I Pujol, Barcelona, Spain; and 8Royal Free Univ., London, UK |
| 800 | Hepatitis C Co-infection Increases Mortality in HIV-infected U.S. Veterans Treated with Highly Active Antiretroviral Therapy L Backus*1, B Phillips1, D Boothroyd1, J Burgess2, M Rigsby2, and S Chang1 1Ctr. for Quality Management in Publ. Hlth., Veterans Hlth. Administration, Palo Alto, CA, USA and 2Natl. HIV and Hepatitis C Prgm. Office, Veterans Hlth. Administration, Washington, DC, USA |
| 801 | Role of RANTES Gene Polymorphisms in HIV Infection Is Neutralized by HCV Co-infection G Ahlenstiel*1, A Iwan1, J Nattermann1, J K Rockstroh1, H H Brackmann2, B Kupfer3, B Matz3, O Landt4, T Sauerbruch1, U Spengler1, R P Woitas1, and BMBF, Kompetenznetz HIV/AIDS 1Univ. of Bonn, Germany; 2Inst. of Experimental Hematology, Univ. of Bonn, Germany; 3Inst. of Med. Microbiology and Immunology, Univ. of Bonn, Germany; and 4TIB MOLBIOL Synthesis Lab., Berlin, Germany |
| 802 | GBV-C Infection Does Not Influence Chemokine/Cytokine Expression Patterns in HIV-1-infected Patients M Giménez-Barcons*, A LLano, J A Esté, B Clotet, and M A Martinez Fndn. irsiCaixa, Hosp. Univ. Germans Trias i Pujol, Barcelona, Spain |
| 803 | Evaluation of HIV-1- and GBV-C-specific T-cell Responses in Individuals Infected with HIV-1 and GB Virus C M M Addo*1, M R Perkins1, A Rathod1, T M Allen1, R Draenert1, A Kim1, C Verrill1, M N Johnston1, A G Wurcel1, C Corcoran1, M Altfeld1, E S Rosenberg2, D Zdunek3, G Hess3, B D Walker1, and GBV-C Study group 1Partners AIDS Res. Ctr., Massachusetts Gen. Hosp., Boston, USA; 2Massachusetts Gen. Hosp., Boston, MA, USA; and 3Roche Diagnostics, Penzberg, Germany |
| 804 | Effect of GBV-C Acquisition by Blood Transfusion on HIV RNA and CD4 Parameters B Custer*1, M Laycock1, D Zdunek2, G Hess3, and M Busch4 1Blood Ctrs. of the Pacific, San Francisco, CA, USA; 2Roche Diagnostics, Penzburg, Germany; 3Roche Diagnostics, Mannheim, Germany; and 4Blood Systems Inc. Phoenix, AZ, USA and Blood Ctrs. of the Pacific, San Francisco, CA, USA |
| 805 | Improved in vitro Survival of PBMC in GBV+ HIV-infected Patients: Role of Apoptosis and Cell Proliferation N Aslan1, H Wedemeyer1, H Heiken2, T Kaiser1, B Kuhlmann3, M Stoll2, R E Schmidt2, M P Manns1, and H L Tillmann*1 1Hannover Med. Sch., Germany; 2Clin. Immunology, Hannover Med. Sch., Germany; and 3Private Practice, Hannover, Germany |
| 806 | Loss of GB Virus C Viremia over Time Is Associated with Faster HIV Disease Progression among HIV+ Homosexual Men with an Imputed Date of Seroconversion A Van der Bij*1, N Kloosterboer2, M Prins1, B Boeser-Nunnink2, M Bakker3, R Coutinho1,3, and H Schuitemaker2 1Municipal Hlth. Svc., Amsterdam, The Netherlands; 2Sanquin Res. and Landsteiner Lab., Amsterdam, The Netherlands; and 3Univ. of Amsterdam, The Netherlands |
| 807 | Determinants of HCV RNA Level among HIV/HCV Co-infected Women T Shahidyazdani*, W Du, M Nowicki, M DeGiacomo, A Kovacs, and Women's Interagency HIV-1 Study Univ. of Southern California, Los Angeles, USA |
| 808 | Concurrent Infection with Multiple Hepatitis C Virus Genotypes Is Associated with Faster HIV Disease Progression L van Asten*1, G Rezza2, J R Robertson3, R Brettle4, J McMenamin5, I Hernandez Aguado6, R Zangerle7, F Boufassa8, B Broers9, S Bruisten1, R A Coutinho1,10, M Prins1, and For the European and Italian Seroconverter studies 1Municipal Hlth. Svc., Amsterdam, The Netherlands; 2Inst. Superiore di Sanita, Rome, Italy; 3Muirhouse Med. Group, Edinburgh, Scotland; 4Western Gen. Hosp., Edinburgh, Scotland; 5Scottish Ctr. for Infection and Environmental Hlth., Glasgow, Scotland; 6Miguel Hernandez Univ., Alicante, Spain; 7Univ. of Innsbruck, Austria; 8Hosp. de Bicêtre, Le Kremlin Bicêtre, France; 9Geneva Univ. Hosp., Switzerland; and 10Univ. of Amsterdam, The Netherlands |
| 809 | Serum Markers of Liver Fibrosis in HIV/HCV-infected Adults S Mehta*1, K Bhaskar2, M Sulkowski1, J Astemborski1, D Thomas1, R Moore1, and N Afdhal2 1Baltimore, MD, USA and 2Boston, MA, USA |
| 810 | Influence of Antiretroviral Drugs on Liver Fibrosis in HIV-infected Patients with Chronic Hepatitis C J Macias*1, V Castellano1, N Merchante1, R B Palacios1, J A Mira1, C Saez4, J A Garcia-Garcia1, F Lozano1, J M Gomez-Mateos1, and J A Pineda1 1Hosp. Univ. de Valme, Seville, Spain and 4Hosp. Univ. Virgen del Rocio, Seville, Spain |
| 811 | Evaluation of HCV RNA and Liver Injury in HCV/HIV Co-infected Patients Initiating Lopinavir/r or Nelfinavir-based Therapy K E Sherman*1, N J Shire1, P Cernohous2, S D Rouster1, B Da Silva2, J Moseley2, and S Brun2 1Univ. of Cincinnati, OH, USA and 2Abbott Labs., Abbott Park, IL, USA |
| 812 | Hepatic Steatosis and Associated Histological Findings in HIV/HCV Co-infected Patients K M Marks*, L M Petrovic, A H Talal, M P Murray, R M Gulick, and M J Glesby Weill Med. Coll. of Cornell Univ., New York, NY, USA |
| 813 | Factors that Affect Fibrosis Progression Rate in Hispanic HIV+ Patients Who Are Co-infected with HCV M Rodríguez-Torres*1,2, C Ríos-Bedoya2, J Rodriguez-Orengo3, A Fernández4, and V Pérez-Ramos1 1Fndn. de Investigación de Diego, Santurce, PR, USA; 2Ponce Sch. of Med., PR, USA; 3Univ. of Puerto Rico, Recinto de Ciencias Médicas, San Juan, USA; and 4Univ. Pathologists, San Juan, PR, USA |
| 814 | Fibrosis Damage in Liver Biopsy Specimens from 354 HIV-HCV Co-infected Patients: Role of Persistently Normal Alanineaminotrasferase C Uberti-Foppa*, A De Bona, L Galli, D Ciuffreda, G Sitia, G Gallotta, C Sagnelli, C Paites, and A Lazzarin HSR Hosp, Milan, Italy |
| 815 | Hepatitis C Related Liver Fibrosis Progression among HIV+ and HIV- Injection Drug Users L Wilson*, M Torbenson, J Astemborski, D Hoover, C Spoler, R Rai, D Vlahov, S Strathdee, M Sulkowski, U Hamper, and D Thomas Johns Hopkins Sch. of Med. and Sch. of Publ. Hlth., Baltimore, MD, USA |
| 816 | Severity and Determinants of Liver Histology Among Randomly Selected HIV/HCV Co-infected Adults S H Mehta*, D L Thomas, M Torbenson, J Astemborski, R E Chaisson, R D Moore, and M S Sulkowski Johns Hopkins Univ., Baltimore, MD, USA |
| 817 | The Impact of the Hepatitis C virus on CD4 Response Post Initiation of HAART among Patients Enrolled in Clinical Trials C Zala*, P Patterson, C Ochoa, A Krolewiecki, R Quercia, A Federico, H Perez, and P Cahn Fndn. Huesped, Buenos Aires, Argentina |
